Pretreatment effect of running exercise on HSP70 and DOX-induced cardiotoxicity

Asian Pac J Cancer Prev. 2012;13(11):5849-55. doi: 10.7314/apjcp.2012.13.11.5849.

Abstract

Objective: The purpose of this study was to determine pretreatment effects of moderate-term endurance training before the various dosages (10 and 20 mg.kg(-1)) of DOX on a heat shock protein (HSP70 kda) and cardiotoxicity in heart tissue.

Methods: Forty-eight male rats were randomly assigned to nontraining (NT) and training (T) groups and three subgroups; DOX10 mg.kg(-1) and DOX20 mg.kg(-1) and saline treatment. The training program included treadmill running between 25-39 min/day and 15-17 m/min, 5 days/wk for 3 wk.

Result: DOX administration, in particularly with 20 mg.kg(-1), caused up-regulation of oxidants and cardiac damage (MDA, CK, CPK-MB and CK/ CPK-MB) and down-regulation of cardioprotection (HSP70, SOD) markers, as compared to NT+saline group. Pretreatment effect of treadmill running endurance exercise in the presence of DOX with 10 mg.kg(-1) caused a significant increase in HSP70, SOD and a significant decrease in MDA and insignificant decrease in CK, CPK-MB and CK/CPK-MB, in comparisonT+DOX10 with NT+DOX10 group. However, there was no significant difference between T+DOX10 mg.kg(-1) and T+DOX20 mg.kg(-1) in the aforesaid markers.

Conclusion: Dox-induced cardiotoxicity is related to oxidative stress. Our study suggests that pretreatment with endurance exercise may be considered as a potentially useful strategy to improve myocardial tolerance against single dose DOX-induced oxidative damage.

MeSH terms

  • Animals
  • Antibiotics, Antineoplastic / pharmacology*
  • Biomarkers / analysis*
  • Doxorubicin / pharmacology*
  • Exercise Therapy*
  • HSP70 Heat-Shock Proteins / metabolism*
  • Heart Diseases / chemically induced
  • Heart Diseases / metabolism
  • Heart Diseases / prevention & control*
  • Male
  • Oxidative Stress
  • Physical Conditioning, Animal
  • Rats
  • Rats, Wistar
  • Running*

Substances

  • Antibiotics, Antineoplastic
  • Biomarkers
  • HSP70 Heat-Shock Proteins
  • Doxorubicin